The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in increased expression of BAX protein]]; wedelolactone inhibits the reaction [Oxygen results in increased expression of BAX protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in decreased expression of BCL2 protein]]; wedelolactone inhibits the reaction [Oxygen results in decreased expression of BCL2 protein]
wedelolactone inhibits the reaction [Methamphetamine results in increased cleavage of and results in increased activity of CASP3 protein]; wedelolactone inhibits the reaction [Quinolinic Acid results in increased activity of CASP3 protein] 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in increased cleavage of CASP3 protein]]; wedelolactone inhibits the reaction [Oxygen results in increased cleavage of CASP3 protein]
wedelolactone inhibits the reaction [Dimethyl Sulfoxide results in increased expression of EDNRB mRNA]; wedelolactone inhibits the reaction [Dimethyl Sulfoxide results in increased expression of EDNRB protein]; wedelolactone inhibits the reaction [Particulate Matter results in increased expression of EDNRB mRNA]; wedelolactone inhibits the reaction [Particulate Matter results in increased expression of EDNRB protein]; wedelolactone inhibits the reaction [Smoke results in increased expression of EDNRB protein]; wedelolactone inhibits the reaction [TNF protein results in increased expression of EDNRB mRNA]; wedelolactone inhibits the reaction [TNF protein results in increased expression of EDNRB protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in increased expression of FTH1 protein]]; wedelolactone inhibits the reaction [Oxygen results in decreased expression of FTH1 protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in increased expression of GPX4 protein]]; wedelolactone inhibits the reaction [Oxygen results in decreased expression of GPX4 protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in increased secretion of IL18 protein]]; wedelolactone inhibits the reaction [Oxygen results in increased secretion of IL18 protein]
wedelolactone inhibits the reaction [Quinolinic Acid results in increased expression of IL1B protein] 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in increased secretion of IL1B protein]]; wedelolactone inhibits the reaction [Oxygen results in increased secretion of IL1B protein]
wedelolactone inhibits the reaction [TNF protein results in increased expression of IL6 mRNA] wedelolactone inhibits the reaction [Quinolinic Acid results in increased expression of IL6 protein]
wedelolactone inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein] [wedelolactone results in decreased activity of IKBKB protein] which results in decreased phosphorylation of NFKBIA protein
wedelolactone inhibits the reaction [Methamphetamine results in increased cleavage of PARP1 protein] Acetylcysteine inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein]; Buthionine Sulfoximine promotes the reaction [wedelolactone results in increased cleavage of PARP1 protein]; CAT protein inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein]; S-ethyl glutathione inhibits the reaction [wedelolactone results in increased cleavage of PARP1 protein]
wedelolactone inhibits the reaction [TNF protein results in increased expression of RELA protein] wedelolactone affects the localization of and results in decreased activity of RELA protein; wedelolactone inhibits the reaction [Palmitic Acid affects the localization of and results in increased activity of RELA protein]
[wedelolactone results in decreased activity of SLC22A6 protein] which results in increased susceptibility to and results in increased activity of aristolochic acid I
[wedelolactone results in decreased activity of SLC22A8 protein] which results in increased susceptibility to and results in increased activity of aristolochic acid I
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in increased expression of SLC7A11 protein]]; wedelolactone inhibits the reaction [Oxygen results in decreased expression of SLC7A11 protein]
2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in decreased expression of TFRC protein]]; wedelolactone inhibits the reaction [Oxygen results in increased expression of TFRC protein]
wedelolactone inhibits the reaction [TNF protein results in increased expression of EDNRB mRNA]; wedelolactone inhibits the reaction [TNF protein results in increased expression of EDNRB protein]; wedelolactone inhibits the reaction [TNF protein results in increased expression of RELA protein]; wedelolactone inhibits the reaction [TNF protein results in increased phosphorylation of CHUK protein]; wedelolactone inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein] 2-(1,3-benzodioxol-5-yl)-N-(5-methyl-4-(1-(2-methylbenzoyl)-2,3-dihydroindol-5-yl)-1,3-thiazol-2-yl)acetamide inhibits the reaction [wedelolactone inhibits the reaction [Oxygen results in increased secretion of TNF protein]]; wedelolactone inhibits the reaction [[Cisplatin co-treated with TNF protein] results in increased phosphorylation of JUN protein]; wedelolactone inhibits the reaction [Oxygen results in increased secretion of TNF protein] wedelolactone inhibits the reaction [TNF protein results in increased abundance of Dinoprostone]; wedelolactone inhibits the reaction [TNF protein results in increased abundance of Thromboxane B2]; wedelolactone inhibits the reaction [TNF protein results in increased expression of IL6 mRNA]; wedelolactone inhibits the reaction [TNF protein results in increased expression of PTGS2 protein]
browse the term
